Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Thyroid Nodule 1Thyroid Neoplasms 1Thyroid Diseases 1Parathyroid Neoplasms 1Parathyroid Diseases 1Opioid-Related Disorders 1Goiter 1Agnosia 1

Interventions

lenvatinib 3cabozantinib 2Thyrotropin Alfa 2vandetanib 1trametinib 1sintilimab 1selpercatinib 1pralsetinib 1pembrolizumab 1pazopanib 1palbociclib 1olaparib 1larotrectinib 1dabrafenib 1anlotinib 1acetaminophen, codeine drug combination 1Tramadol 1Thyroxine 1Technetium Tc 99m Sestamibi 1Sunitinib 1Sodium Chloride 1Ondansetron 1Negative-Pressure Wound Therapy 1Indocyanine Green 1Fentanyl 1Conversion to Open Surgery 1Capsules 1Aprepitant 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Thyroid Neoplasms × Capsules × Clear all
NCT03469310 2021-05-11

Minimizing Narcotic Analgesics After Endocrine Surgery

DHR Health Institute for Research and Development

Phase 4 Completed
126 enrolled
Head & Neck

Agnosia, Goiter, Opioid-Related Disorders, Parathyroid Diseases, Parathyroid Neoplasms, Thyroid Diseases, Thyroid Neoplasms, Thyroid Nodule

Data powered by HemOnc (CC BY 4.0) Colophon âš¡